Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs

Abstract Endpoint HbA1c

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes research and clinical practice 2012-06, Vol.96 (3), p.e66-e69
Hauptverfasser:	Dungan, Kathleen M, Buse, John B, Herman, William H, Arakaki, Richard F, Jiang, Honghua H, Jacobson, Jennie G, Fahrbach, Jessie L
Format:	Artikel
Sprache:	eng
Schlagworte:	1,5-Anhydroglucitol Blood Glucose - drug effects Blood Glucose - metabolism Deoxyglucose - administration & dosage Deoxyglucose - therapeutic use Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Dose-Response Relationship, Drug Drug Therapy, Combination Endocrinology & Metabolism Female Glargine Humans Hypoglycemia - blood Hypoglycemia - drug therapy Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - therapeutic use Insulin Glargine Insulin Lispro - administration & dosage Insulin Lispro - therapeutic use Insulin lispro mix 25 Insulin, Long-Acting - administration & dosage Insulin, Long-Acting - therapeutic use Male Middle Aged Treatment Outcome Weight Gain - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!